IDH2 and glioblastoma: By comparing the signature probes of IDH, TERTp, ATRX, and chr1p19q codel with the Glioblastoma-CpG island Methylator Phenotype (G-CIMP) signature18, we found no significant overlap among these five probe signatures (Fig. 1C).